Your browser doesn't support javascript.
loading
Estrogen receptor {beta}1 expression is regulated by miR-92 in breast cancer.
Al-Nakhle, Hakeemah; Burns, Philip A; Cummings, Michele; Hanby, Andrew M; Hughes, Thomas A; Satheesha, Sampoorna; Shaaban, Abeer M; Smith, Laura; Speirs, Valerie.
Afiliação
  • Al-Nakhle H; Leeds Institute of Molecular Medicine, University of Leeds, Leeds, United Kingdom.
Cancer Res ; 70(11): 4778-84, 2010 Jun 01.
Article em En | MEDLINE | ID: mdl-20484043
ABSTRACT
Estrogen receptor beta1 (ERbeta1) downregulation occurs in many breast cancers, but the responsible molecular mechanisms remain unclear. Here, we report that levels of ERbeta1 expression are negatively regulated by the microRNA miR-92. Expression analysis in a cohort of primary breast tumors confirmed a significant negative correlation between miR-92 and both ERbeta1 mRNA and protein. Inhibition of miR-92 in MCF-7 cells increased ERbeta1 expression in a dose-dependent manner, whereas miR-92 overexpression led to ERbeta1 downregulation. Reporter constructs containing candidate miR-92 binding sites in the 3'-untranslated region (UTR) of ERbeta1 suggested by bioinformatics analysis confirmed that miR-92 downregulated ERbeta1 via direct targeting of its 3'-UTR. Our results define a potentially important mechanism for downregulation of ERbeta1 expression in breast cancer.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / MicroRNAs / Receptor beta de Estrogênio Limite: Female / Humans Idioma: En Ano de publicação: 2010 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / MicroRNAs / Receptor beta de Estrogênio Limite: Female / Humans Idioma: En Ano de publicação: 2010 Tipo de documento: Article